Nicholas Choo ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Abstracts this author is presenting:

• Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer — ESA Young Investigator Scientific Article Award - Basic Science